The British Association for the Study of the Liver is a multi-disciplinary society with over 1,000 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
The British Association for the Study of the Liver aims to disseminate research findings and clinical expertise, to promote opportunities for collaboration in liver research, to provide a voice that can advise and interact with the media and advises policymakers.
The British Association for the Study of the Liver incorporates the British Liver Nurses's Association, the British Viral Hepatitis Group and the British Liver Transplant Group.
Membership covers BASL and all of its special interest groups; BLNA, BVHG and BLTG. Your Annual subscription is used to organise the Annual Meeting held each September and the subscription rate you pay is determined by your job status.
Dr Palak Trivedi (University of Birmingham) winner of the Andy Burroughs Young Investigator Award 2017.
Dr Fotis Sampaziotis (University of Cambridge) winner of the Dame Sheila Sherlock Award 2017 being presented with the award by the previous BASL Secretary Dr David Patch.
Abstract Submission is now Open - BASL2018 runs from 19 - 21 September 2018 at the University of York. For further details visit the BASL Events listing page on our website. The deadline for submitting an abstract is FRIDAY 1st JUNE 2018.
Find out more
Find out more about the work of our committee sub-groups and forums by clicking the logos below. These include The British Viral Hepatitis Group, British Association for the Study of the Liver Nurse Forum and the British Liver Transplant Group.
The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development.
BASL is a multi-disciplinary society with over 1,000 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions.
Members of BASL receive the following benefits:
- discounted registration rates for the annual meeting and other relevant meetings
- eligibility for the BASL Travel Awards (for members below status of Senior Lecturer or Consultant to allow presentation of high-quality UK liver research at International meetings, including the American Association for the Study of Liver Disease)
- eligibility for the prestigious Dame Sheila Sherlock Award (to an emerging researcher in the field of liver disease, for members below status of Senior Lecturer or consultant). Applications are usually submitted to the BASL Committee three months prior to the annual meeting - details are announced.
Click here to find out more about joining us.
Over the last few years there has been increasing discussion about the role of early liver transplantation for patients with severe alcoholic hepatitis not responding to medical treatment. Although this is increasingly being considered in France and the US, uptake of a pilot study of liver transplantation for this condition in the UK over the last few years was extremely low. We are interested therefore to understand where UK clinicians who look after patients with severe alcoholic hepatitis see the role of early liver transplantation in this setting and would therefore be very grateful if you would be able to complete this Survey, which has been BASL endorsed, and should take only 2-3 minutes to complete.
Please find to follow the link to the survey - www.centralnhs.com .
Many thanks for your help
Katie Arndtz, Gastroenterology SpR
Alexander Gimson, Consultant Hepatologist
Michael Allison, Consultant Hepatologist
The 2018 Gilead UK and Ireland Fellowship Programme is now open for grant applications in viral hepatitis.
The aim of the Programme is to support local innovation and best practice in patient care in HIV, viral hepatitis, oncology/haematology, respiratory and invasive fungal disease.
The Programme invites applications from healthcare or allied professionals who are seeking funding for a project that aligns with the goals of the Gilead UK & Ireland Fellowship Programme.
The 2018 Viral Hepatitis Fellowship programme will support projects aligned to the theme:
Systematic HCV testing (or re-engagement of those previously diagnosed) in at-risk populations in community-based services (e.g. community pharmacy, correctional services, etc) including community-based treatment initiation.
To view the application criteria and apply visit: www.gileadgiving.co.uk , all applications must be made via the online form.
Please note that the application period will close on Friday 1 June 2018
For specific application queries, please contact the Gilead UK and Ireland Fellowship Administrators on: firstname.lastname@example.org .
Public Health England (PHE) has recently published a recovery plan on gov.uk to support re-introduction of hepatitis B vaccine in a phased approach during 2018 for lower priority groups mainly vaccinated by occ health and primary care.
View a letter from PHE here: Download PHE letter to stakeholders _hepB vaccine recovery plan 2018.pdf
The link to the recovery plan on the gov.uk website can be found > here.
BASL is offering two competitive awards in 2018 up to a value of £3,000 each to contribute to the costs of an international attachment in clinical liver disease (including liver transplantation and liver surgery) or research into any aspect of liver disease.
Applications are open to any healthcare professional or scientist working in the field of liver disease who are members of BASL, BLNA, BLTG or BASL affiliated groups.
To find out further details and how to apply download the information document here; Download BASL professional development awards final 15.3.18.pdf
The deadline for submitting your application is 17:00 on Friday 29th June 2018.
Applications should be emailed to the BASL Secretariat at email@example.com .
Welcome to the Europe and Canada Practice to Policy® Health Awards Programme
In 2018, Intercept is excited to offer grant support to local and national projects within eligible countries across Europe and Canada. The Europe and Canada Practice to Policy® Health Awards Programme encourages the development of innovative projects which improve the lives of people with primary biliary cholangitis (PBC).
The application window is now open.
Please note that the deadline for applying is Wednesday 6 June 2018.
Visit the website here - https://www.interceptpracticetopolicy.com/eu .
Job Reference: 304-18C011
Employer: University Hospitals Birmingham NHS Foundation Trust - Medical & Dental
Location: Birmingham, Queen Elizabeth Hospital
Salary: £76,761 - £103.490
Closing Date: 31 March 2018
Applications are invited for 2 x 1.0 WTE Hepatology Consultants (10 PAs) to join the existing liver medicine team. The successful applicants will work as Transplant Physicians within the Department of Hepatology. The department consists of 14 Consultant Hepatologists (including 6 Transplant Physicians and 6 Academic Hepatologists), 3 Hepatology Fellows and 8 specialist hepatology trainees. The successful applicant will contribute to clinical service development and delivery as a member of the hepatology team, working closely with colleagues in the Liver and Hepatobiliary Unit, Interventional Radiology and Oncology.
Full details can be found on the NHS Jobs site > here.
The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2018 awards round on Tuesday 13th February. The final closing date for applications to the ACCEA is 17:00 on Thursday 12th April.
Application for BASL support
If you would like to apply for BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs as detailed below:
- Supplementary CV Questionnaire: Research & Innovation Assessment
- Supplementary CV Questionnaire: Teaching & Training Assessment
- Supplementary CV Questionnaire: Medical Leadership & Managing a High Quality Service Assessment.
Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.
Full application guidance can be found on the ACCEA website including the use of the Supplementary Forms by clicking here.
In addition BASL requires a short piece to accompany your application stating why you feel you should be supported by BASL.
The deadline for applying for BASL support is 17:00 on Friday 16th March 2018.
All applications must go through the ACCEA on line system, should you need a downloadable form to send to BASL these can be found on the ACCEA website by clicking here.
As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.
To apply for BASL support, please follow the steps below:
1. Send a completed ACCEA Application Form, along with a short piece as to why you feel you should be supported by BASL, to the BASL Secretariat, Judy.Hawksworth@execbs.com by 17:00 on Friday 16th March 2018.
Please understand that in fairness to all applicants, late submissions will not be considered.
2. All applicants are asked to provide the name of an individual who could write a supporting citation when submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.
3. You must submit your own application to ACCEA online by their deadline 17:00 on Thursday 12th April 2018. This is your own responsibility.
4. If you are in receipt of BASL support then BASL will upload your citation. You must ensure that your application is uploaded to the ACCEA website at least one week before the deadline - 17:00 on Thursday 5th April 2018, so that BASL has sufficient time to upload your citations onto your application on the ACCEA website.
Read the summary of the report from the first BVHG and BASL Best Practice for ODN Stakeholders Meeting which was held on the 10–11 January 2018 in Manchester on the BVHG page of the website by clicking here.
The report highlights the limitations of the current HCV treatment model, and provides suggestions on how it can be modified and improved. The report describes best practice examples for eliminating HCV for ODNs to take and adapt to work in their area. The intention is that this information will provide all ODNs with a framework to develop the 5-year plans needed to meet their CQUIN requirement, and importantly to also leave them well placed to deliver on the World Health Organisations goal of HCV elimination by 2030.
The BLNA is delighted to announce its forthcoming April meeting – Innovations in caring for people with or at risk of liver disease
The meeting will be held at Austin Court in Birmingham on Friday 27th April 2018. The programme reflects innovations in care and the dynamic nature of liver nursing. Topic areas will include alcohol, hepatitis C and primary biliary cholangitis. We have invited a service user to discuss the lived experience of liver disease, person focussed sessions are always well received by offering nurses insight and helping to illuminate the care we give to people with liver disease. Acute on chronic liver failure will be complemented by the “Liver Diseases in Bite Size Pieces” session which will focus on features of decompensated cirrhosis. The UK government is currently out to consultation to change the way that organ donation works in England; we will debate the pros and cons of the two different systems. In 2018 there will be a number of changes to the way that donor livers are allocated and we will investigate what effect this might have for liver transplant recipients. As technology becomes a more integral part of our work, we will be looking at a liver app that supports assessment and diagnosis of liver conditions.
Registration is now open and programme topics* covered include:
Acute on Chronic Liver Disease
Features of decompensated cirrhosis
National allocation of donor livers
Primary Biliary Cholangitis
Lived experience of liver disease
Organ donation debate
* subject to change
*Are you a BLNA member yet? If not, you are missing out on considerable benefits for a yearly fee of £20, including a significant discount on your registration fee for this meeting so we encourage you to sign up before registering for the meeting.
For any enquiries please contact: firstname.lastname@example.org or telephone 01543 442154.
The AMMF Cholangiocarcinoma Conference is a UK-focused day that includes speakers from several of the areas of cholangiocarcinoma research that AMMF is currently supporting, plus medics at the forefront of the treatment and care of the cholangiocarcinoma patient.
The venue is The Radisson Blu Hotel, very close to London Stansted Airport. There is onsite parking, and the hotel is just minutes' walk from the air and rail terminal. The day will begin with registration from 8.30am for a 9.30 am start, and the main conference will finish at 5.30pm.
For full information visit the conference page on the AMMF website > here.
To register click > here.
The Asian Pacific Association for the Study of the Liver (APASL) Single Topic Conference will be held on May 11-13, 2018 in Yokohama, Japan.
Under the theme of “HCC: Strategy in the New Era”, the conference program will present high-quality content based on up-to-date information and cutting edge lectures by eminent researchers, in order to reconfirm the achievement of better basic and clinical practice in the field of HCC.
The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers on significant developments on the theme of “HCC: Strategy in the New Era”. The program will also provide the latest information and fresh ideas for hepatologists.
Visit the conference website to find out further details by clicking > here.
Key conference date lines can be found below:
Abstract Submission Open - 2 October 2017 - 31 January 2018
Early Bird Registration Deadline - 28 February 2018
Pre-registration will close - 13 April 2018
The Clinics and Science in Hepatology 2018 meeting is a 1-day educational meeting taking place on Saturday 19 May at the Hilton Birmingham Metropole.
The programme has been developed by Course Directors Geoffrey Dusheiko (UK) and Maria Buti (Spain), alongside an expert Scientific Committee comprising Thomas Berg (Germany), Christophe Hézode (France) and Lawrence Serfaty (France).
This meeting is intended to educate ~100–150 practising physicians treating patients with HBV, HCV and NAFLD in Europe and the Middle East and CME accreditation of 6 credits is anticipated for this event.
The meeting is free to attend, with participation grants available for attendees to support their travel expenses and accommodation (for 1 night prior to the meeting, and subject to meeting the criteria and where allowed according to their country regulations).
Register to guarantee your place www.CSHep2018.com
‘Professor Massimo Pinzani of UCL and his team will once again be running the 2018 Hepatology Postgraduate Course which for this year is combined with the Sheila Sherlock Course making a unique opportunity for the attending Postgraduates.
The aim of the course is to provide a strong foundation in hepatology and equip both future and current gastroenterologists and general physicians to become more expert in the field.
By the end of the course, you will be able to:
• Identify all areas of the JRCPTB curriculum in hepatology which have been covered within the course and apply them to your
own clinical practice.
• Apply learnt knowledge to the Specialty Certificate Examination in Gastroenterology
• Contribute to the development of Hepatology services within your own Hospitals
• Be more confident in managing hepatology patients on the acute medical take
• Have a good breadth of knowledge into the science underpinning Hepatology research today.
This three day course aims to provide:
• Clinically focused updates
• Comprehensive coverage of the pathogenesis, diagnosis, investigation and management of patients with acute and chronic liver disease
• Topics mapped to the (JRCPTB) curriculum in hepatology with learning outcomes that can be uploaded to the JRCPTB e-portfolio
• A deeper understanding of the basic science of liver disease
• Interactive teaching focusing on SCE style SBA questions and real cases’
REGISTER > here.
Professor Gideon Hirschfield and Dr James Ferguson, of the University of Birmingham and Queen Elizabeth Hospital Liver Unit are organising the 6th Annual Birmingham Liver Course, on 24-25 May 2018. The meeting will cover practical and pressing issues in the management of advanced liver disease with speakers from around the country who are experts in their field. Using an interactive approach, we are sure this course will prove to be very popular and of interest to trainees, consultants, nurses and allied health professionals.
Download a copy of the programme here; Download Bham Liver Course May 2018.pdf
For further details and to Register click > here or visit the University of Birmingham Website; https://www.birmingham.ac.uk/facilities/mds-cpd/conferences/liver-course/index.aspx .
Save the Date
The Royal Free Hospital and British Medical Ultrasound Course are running an International Hepatology Ultrasound Course. The course is a comprehensive ultrasound course in hepatology to be held over 3 days. Attendees will benefit from hands-on training to compliment the essential theory sessions. The lectures will range from basic ultrasound to the assessment of chronic liver disease, vascular and biliary pathology to the latest advances such as contrast enhanced ultrasound and tissue elastography. Attendees will have the opportunity to scan both healthy volunteers and pre diagnosed patients.
Venue: The Royal Free Hospital.
More information will follow, however advance bookings can be made by clicking > here.
BASL Professional Development Awards - Applications Open
We are offering 2 competitive awards in 2018 up to a value of £3,000 each to contribute to the costs of an international attachment in clinical liver disease (including liver transplantation and liver surgery) or research into any aspect of liver disease.
Read the article on the BASL News Page > here.
We are pleased to announce that the liver disease quality standard (QS152) has been published on the NICE website.
You can view the quality standard by clicking > here.
BASL has formally supported the liver disease quality standard.
Click here to view the BASL Newsletter - February 2018.
The BASL Nurse Toolkits were developed following conversations with nurse specialists. These and a later email survey identified training needs to help nurses meet the liver nurse competencies. To access the Learning Toolkits sign in as a BASL Member and click on Manage Account